Mark Berger - Feb 18, 2025 Form 4 Insider Report for Genprex, Inc. (GNPX)

Role
Chief Medical Officer
Signature
/s/ Mark Berger
Stock symbol
GNPX
Transactions as of
Feb 18, 2025
Transactions value $
-$240
Form type
4
Date filed
2/19/2025, 08:01 PM
Previous filing
Dec 6, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GNPX Common Stock Tax liability -$240 -585 -2.54% $0.41 22.5K Feb 18, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld on February 18, 2025 to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") previously granted under the Genprex, Inc. (the "Company") 2018 Equity Incentive Plan.